| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8790705 | American Journal of Ophthalmology | 2018 | 20 Pages |
Abstract
Low-dose iodine-125 plaque brachytherapy (67.5-81 Gy at tumor apex) provides safe and effective tumor control for juxtapapillary choroidal melanoma and may be associated with reduced radiation toxicity. Larger trials are needed to determine the optimal therapeutic dose for juxtapapillary choroidal melanoma.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Patrick Oellers, Yvonne M. Mowery, Bradford A. Perez, Sandra Stinnett, Pradeep Mettu, Lejla Vajzovic, Kim Light, Beverly A. Steffey, Jing Cai, Jonathan J. Dutton, Edward G. Buckley, Edward C. Halperin, Lawrence B. Marks, David G. Kirsch,